AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 289: E627-E633, 2005. First published May 24, 2005; doi:10.1152/ajpendo.00079.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/4/E627    most recent
00079.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulder, A. H.
Right arrow Articles by Bosch, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulder, A. H.
Right arrow Articles by Bosch, R. R.

Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation

Alexandra H. Mulder,1 Cees J. Tack,1 André J. Olthaar,2 Paul Smits,3 Fred C. G. J. Sweep,2 and Remko R. Bosch2,4,5

1Division of General Internal Medicine, Department of Medicine, Departments of 2Chemical Endocrinology,3Pharmacology and Toxicology, and 4Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen; and 5Department of Veterinary Pharmacy, Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Utrecht, Utrecht, The Netherlands

Submitted 19 February 2004 ; accepted in final form 23 May 2005

Activation of the sympathetic nervous system inhibits insulin-stimulated glucose uptake. However, the underlying mechanisms are incompletely understood. Therefore, we studied the effects of catecholamines on insulin-stimulated glucose uptake and insulin-stimulated translocation of GLUT4 to the plasma membrane in 3T3-L1 adipocytes. We found that epinephrine (1 µM) nearly halved insulin-stimulated 2-deoxyglucose uptake. The {beta}-adrenoceptor antagonist propranolol (0.3 µM) completely antagonized the inhibitory effect of epinephrine on insulin-stimulated glucose uptake, whereas the {alpha}-adrenoceptor antagonist phentolamine (10 µM) had no effect. When norepinephrine was used instead of epinephrine, the results were identical. None of the individual selective {beta}-adrenoceptor antagonists (1 µM, {beta}1: metoprolol, {beta}2: ICI-118551, {beta}3: SR-59230A) could counteract the inhibitory effect of epinephrine. Combination of ICI-118551 and SR-59230A, as well as combination of all three selective {beta}-adrenoceptor antagonists, abolished the effect of epinephrine on insulin-stimulated glucose uptake. After differential centrifugation, we measured the amount of GLUT1 and GLUT4 in the plasma membrane and in intracellular vesicles by means of Western blotting. Both epinephrine and norepinephrine reduced insulin-stimulated GLUT4 translocation to the plasma membrane. These results show that {beta}-adrenergic (but not {alpha}-adrenergic) stimulation inhibits insulin-induced glucose uptake in 3T3-L1 adipocytes, most likely via the {beta}2- and {beta}3-adrenoceptor by interfering with GLUT4 translocation from intracellular vesicles to the plasma membrane.

catecholamines; glucose transporter 4



Address for reprint requests and other correspondence: C.G.J. Sweep, Dept. of Chemical Endocrinology (530), Radboud Univ. Nijmegen Medical Centre, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands (e-mail: f.sweep{at}ace.umcn.nl)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.